TY - JOUR KW - Substance Use Disorders -- Drug Therapy KW - Hospital Programs KW - Naltrexone -- Therapeutic Use KW - Buprenorphine -- Therapeutic Use KW - Outcomes (Health Care) KW - Human KW - Descriptive Statistics KW - Male KW - Female AU - Sarah E. Wakeman AU - Martha Kane AU - Elizabeth Powell AU - Sydney Howard AU - Christopher Shaw AU - Laura Kehoe AU - Joy Rosen AU - Joan Quinlan AU - Susan Regan A1 - AD - Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA; Department of Nursing and Patient Care Services, Massachusetts General Hospital, Boston, MA, USA; Center for Community Health Improvement, Massachusetts General Hospital, Boston, MA, USA BT - Substance Abuse C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use CP - 4 CY - Philadelphia, Pennsylvania DO - 10.1080/08897077.2020.1846664 IS - 4 JF - Substance Abuse LA - English M1 - Journal Article PB - Taylor & Francis Ltd PP - Philadelphia, Pennsylvania PY - 2021 SN - 0889-7077 SP - 767 EP - 774 EP - T1 - A hospital-wide initiative to redesign substance use disorder care: Impact on pharmacotherapy initiation T2 - Substance Abuse TI - A hospital-wide initiative to redesign substance use disorder care: Impact on pharmacotherapy initiation U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use U3 - 10.1080/08897077.2020.1846664 VL - 42 VO - 0889-7077 Y1 - 2021 Y2 - 10 ER -